Treatment decision making experience of older adults with lymphoma v1
Research type
Research Study
Full title
A qualitative study exploring how adults aged 65 years or older with a new diagnosis of lymphoma make decisions about their treatment
IRAS ID
302049
Contact name
Jane Gibson
Contact email
Sponsor organisation
University of Salford
Duration of Study in the UK
2 years, 0 months, 0 days
Research summary
As people are living longer, there are more older people at risk of developing health problems, including cancer. As part of the normal ageing process there is also an increased risk of developing frailty. Frailty can result in difficulties coping with cancer treatment, negatively impact on an older adult’s experience of cancer treatment and lead to poorer outcomes, including survival. This qualitative study will explore the experiences of treatment decision making of older adults with a new diagnosis of lymphoma (blood cancer). By understanding the experience of the treatment decision process from the perspective of older adults with lymphoma, this research would enable healthcare professionals in the future to tailor the necessary assessment, information, and support when caring for older adults with lymphoma. The study will involve one semi-structured telephone or video interview with participants aged 65 years or older with a new diagnosis of aggressive lymphoma within the first 12 weeks of starting chemotherapy. Participants will be recruited from an NHS Trust lymphoma team and Lymphoma Action patient charity. The study is sponsored by the University of Salford.
REC name
East of Scotland Research Ethics Service REC 1
REC reference
21/ES/0089
Date of REC Opinion
28 Sep 2021
REC opinion
Further Information Favourable Opinion